DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Gómez-García F, Epstein D, Isla-Tejera B. et al.
Short-term efficacy and safety of new biological agents targeting the
interleukin-23–T helper 17 pathway for moderate-to-severe plaque
psoriasis: a systematic review and network meta-analysis.
Br J Dermatol 2017;
176: 594-603
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.